drugset / Trial / NCT02035696
Safety and Immunogenicity of a Four Influenza Vaccines in Children Ages 6 Months Old to Less Than 48 Months Old
RandomizedParallel-groupQuadruple-blindPrevention
Summary
To evaluate the safety and immunogenicity of four influenza vaccines in children 6 months to \< 48 months of age
Timeline
- Start
- 2013-12
- Primary completion
- 2014-06
- Completion
- 2014-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Trivalent influenza vaccine (TIVc) | Unknown | 0.25 ml | — |
| Subject | Trivalent influenza vaccine (TIVc) | Unknown | 0.5 ml | — |
| Subject | Trivalent influenza vaccine (TIVc) | Unknown | 0.75 ml | — |
| Comparator | Trivalent influenza vaccine-licensed | Unknown | 0.25 ml | Intramuscular |
| Comparator | Trivalent influenza vaccine-licensed | Unknown | 0.5 ml | Intramuscular |